PTHS Pelthos Therapeutics Inc.
$21.90▼ -2.36%
Healthcare
Other
Volume 18.9K
Avg Volume (10D) 49.4K
Key Metrics & Fundamentals
Market Cap
$83.84M
P/E Ratio
–
Div Yield
–%
52W Range
18.19 - 37.50
% vs 50 MA
-16.92%
% vs 200 MA
-13.36%
RSI-14
32.3
MACD Histogram
-0.3300
Beta (1Y vs SPY)
0.26
Free Cash Flow
-$7.67M
Gross Rev
$15.60M
Gross Profit
$2.77M
EBITDA
-$19.71M
COGS
$12.83M
Operating Exp
$20.10M
Operating Income
-$17.32M
EBIT
-$17.32M
Pretax Income
-$23.42M
Net Income
-$23.42M
EPS (Diluted)
-6.62
Price & Volume History
Loading chart…
Recent News
Ligand Pharmaceuticals (LGND): Massive XOMA Acquisition Doubles The Royalty Book
Insider Monkey · Sep 4, 2026 10:44 AM
Pelthos (PTHS) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 20, 2026 1:04 PM
Pelthos Therapeutics Q2 Earnings Call Highlights
MarketBeat · Aug 14, 2026 8:04 AM
Pelthos Therapeutics Inc (PTHS) (Q2 2026) Earnings Call Highlights: Revenue Surges 45% as ...
GuruFocus.com · Aug 13, 2026 11:06 PM
Pelthos Therapeutics Inc. Q2 2026 Earnings Call Summary
Moby · Aug 13, 2026 9:05 PM
Pelthos Therapeutics Inc. (PTHS) Reports Q2 Loss, Lags Revenue Estimates
Zacks · Aug 13, 2026 12:25 PM
Pelthos Therapeutics Announces Second Quarter 2026 Financial Results
GlobeNewswire · Aug 13, 2026 11:10 AM
Earnings To Watch: Pelthos Therapeutics Inc (PTHS) Reports Q2 2026 Result
GuruFocus.com · Aug 12, 2026 1:29 PM
This Biotech Dealmaker — Tied To Merck, Travere — Is In A Profit-Taking Zone
Investor's Business Daily · Aug 6, 2026 8:08 PM
Pelthos Therapeutics to Report Second Quarter 2026 Financial Results on August 13, 2026
GlobeNewswire · Aug 3, 2026 12:00 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See PTHS's money flow as a full page
Social Sentiment
No Reddit posts found for PTHS.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.